David A. Battat
Net Worth

Last updated:

What is David A. Battat net worth?

The estimated net worth of Mr. David A. Battat is at least $18,190,000 as of 1 Jul 2024. He has received compensation worth at least $18,190,000 in Atrion Corporation.

What is the salary of David A. Battat?

Mr. David A. Battat salary is $1,070,000 per year as Pres & Chief Executive Officer in Atrion Corporation.

How old is David A. Battat?

Mr. David A. Battat is 55 years old, born in 1970.

What stocks does David A. Battat currently own?

As insider, Mr. David A. Battat owns shares in one company:

Company Title Shares Price per share Total value
Atrion Corporation (ATRI) Pres & Chief Executive Officer 39,400 $0 $0

What does Atrion Corporation do?

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

David A. Battat insider trading

Atrion Corporation

Transaction Date Security Shares Price per share Total value Source
Option
common stock 310 N/A N/A
Option
restricted stock units 310 N/A N/A
Option
common stock 310 N/A N/A
Purchase
common stock 300 $300 $90,000
Option
common stock 310 N/A N/A
Option
restricted stock units 310 N/A N/A
Option
Common Stock 2,000 $538 $1,076,000
Option
Stock Options 2,000 $538 $1,076,000
Option
Common Stock 4,000 $538 $2,152,000
Option
Common Stock 12,000 N/A N/A
Option
Common Stock 6,000 $538 $3,228,000
Option
Common Stock 6,000 N/A N/A
Option
Stock Options 15,000 $228.08 $3,421,200
Option
Stock Options 10,000 $228.08 $2,280,800
Option
Stock Options 3,104 $111.06 $344,730
Option
Common Shares 3,104 $111.06 $344,730
Option
Stock Options 896 $111.5 $99,904
Option
Common Shares 896 $111.5 $99,904
Option
Stock Options 10,208 $27.88 $284,548
Option
Common Shares 10,208 $111.28 $1,135,946
Option
Common Shares 10,208 $111.28 $1,135,946
Option
Common Shares 1,972 $111.5 $219,878
Option
Stock Options 1,792 $111.5 $199,808
Purchase
Common Stock 200 $100 $20,000
Purchase
Common Stock 200 $98.94 $19,788

Atrion key executives

Atrion Corporation executives and other stock owners filed with the SEC: